Viewing Study NCT06444269


Ignite Creation Date: 2025-12-24 @ 11:14 PM
Ignite Modification Date: 2026-01-02 @ 2:41 AM
Study NCT ID: NCT06444269
Status: RECRUITING
Last Update Posted: 2025-11-05
First Post: 2024-05-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Precision Medicine in Action: Phase II Trial of Response Adaptive Ablative Pre-operative SPBI (RAPS) and Non-operative Sentinel Lymph Node Biopsy in Patients With Early-stage ER+ Breast Cancer: RAPS Trial
Sponsor: University of Texas Southwestern Medical Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: STU-2024-0561
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators